"AVH's spray on skin technology was developed in Australia and was approved by the US FDA in September 2018.
Revenue growth declined in FY21 when Covid hit. As normal levels of activity in the US economy resume, the number of burns injuries
is returning to pre COVID levels. Access to hospitals for AVH staff is improving as reflected in the recently upgraded guidance for 4Q21.
AVH is pursuing adjacent markets for the treatment of vitiligo and soft tissue injury where clinic trials are underway. Approval is expected in FY23/24 respectively. Approval in Japan is expected by the end of CY21."
Buy, Target Price $9.80.
"AVH's spray on skin technology was developed in Australia and...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.68 |
Change
-0.020(1.18%) |
Mkt cap ! $123.7M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.74 | $1.66 | $735.3K | 434.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3602 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.69 | 3000 | 1 |
View Market Depth
| Last trade - 16.10pm 19/09/2025 (20 minute delay) ? |
| AVH (ASX) Chart |